Published in Carcinogenesis on August 29, 2015
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal (2013) 19.54
Integrated genomic characterization of papillary thyroid carcinoma. Cell (2014) 6.05
Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst (2005) 5.32
I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. Environ Health Perspect (2011) 2.95
A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: thyroid cancer in Ukraine detected during first screening. J Natl Cancer Inst (2006) 2.37
Thyroid cancer incidence among people living in areas contaminated by radiation from the Chernobyl accident. Health Phys (2007) 2.04
Thyroid cancer risk in Belarus among children and adolescents exposed to radioiodine after the Chornobyl accident. Br J Cancer (2010) 1.93
The Chernobyl accident--an epidemiological perspective. Clin Oncol (R Coll Radiol) (2011) 1.82
Spatial normalization of array-CGH data. BMC Bioinformatics (2006) 1.79
Questionnaire- and measurement-based individual thyroid doses in Ukraine resulting from the Chornobyl nuclear reactor accident. Radiat Res (2006) 1.66
Assessing cancer risks of low-dose radiation. Nat Rev Cancer (2009) 1.53
Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. J Clin Endocrinol Metab (2004) 1.38
Risk of thyroid cancer in the Bryansk Oblast of the Russian Federation after the Chernobyl Power Station accident. Radiat Res (2004) 1.33
Rearrangements of NTRK1 gene in papillary thyroid carcinoma. Mol Cell Endocrinol (2009) 1.33
Cyclic AMP-dependent protein kinase phosphorylates merlin at serine 518 independently of p21-activated kinase and promotes merlin-ezrin heterodimerization. J Biol Chem (2004) 1.30
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture. Eur J Endocrinol (2006) 1.29
Nonparametric testing for DNA copy number induced differential mRNA gene expression. Biometrics (2008) 1.27
CGHMultiArray: exact P-values for multi-array comparative genomic hybridization data. Bioinformatics (2005) 1.23
Post-Chornobyl thyroid cancers in Ukraine. Report 1: estimation of thyroid doses. Radiat Res (2005) 1.20
Post-Chernobyl thyroid cancers in Ukraine. Report 2: risk analysis. Radiat Res (2006) 1.17
Copy number and gene expression alterations in radiation-induced papillary thyroid carcinoma from chernobyl pediatric patients. Thyroid (2010) 1.12
Iodine-131 dose dependent gene expression in thyroid cancers and corresponding normal tissues following the Chernobyl accident. PLoS One (2012) 1.12
RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation. Cell Rep (2013) 1.08
RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics. Cancer (2013) 1.04
Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTC. Oncogene (2008) 1.03
Gain of chromosome band 7q11 in papillary thyroid carcinomas of young patients is associated with exposure to low-dose irradiation. Proc Natl Acad Sci U S A (2011) 1.02
DNA quality assessment for array CGH by isothermal whole genome amplification. Cell Oncol (2007) 0.99
Tumor Suppressor NF2 Blocks Cellular Migration by Inhibiting Ectodomain Cleavage of CD44. Mol Cancer Res (2015) 0.91
Matching of array CGH and gene expression microarray features for the purpose of integrative genomic analyses. BMC Bioinformatics (2012) 0.90
CLIP2 as radiation biomarker in papillary thyroid carcinoma. Oncogene (2014) 0.89
Iodine-131 dose-dependent gene expression: alterations in both normal and tumour thyroid tissues of post-Chernobyl thyroid cancers. Br J Cancer (2013) 0.86
Thyroid cancer in Ukraine after the Chernobyl accident (in the framework of the Ukraine-US Thyroid Project). J Radiol Prot (2012) 0.85
Dose-dependent expression of CLIP2 in post-Chernobyl papillary thyroid carcinomas. Carcinogenesis (2015) 0.82
Gene rearrangements in radiation-induced thyroid carcinogenesis. Med Pediatr Oncol (2001) 0.80
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma. J Clin Endocrinol Metab (2006) 1.98
High resolution array-CGH analysis of single cells. Nucleic Acids Res (2006) 1.79
Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients. Radiat Oncol (2013) 1.59
Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. J Clin Endocrinol Metab (2004) 1.38
Simultaneous over-expression of the Her2/neu and PTK6 tyrosine kinases in archival invasive ductal breast carcinomas. J Pathol (2005) 1.30
Radiation resistance due to high expression of miR-21 and G2/M checkpoint arrest in breast cancer cells. Radiat Oncol (2012) 1.12
MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma. Cancer Genet (2012) 1.08
MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer. Am J Pathol (2011) 1.08
RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation. Cell Rep (2013) 1.08
Significance of HER2 low-level copy gain in Barrett's cancer: implications for fluorescence in situ hybridization testing in tissues. Clin Cancer Res (2007) 1.04
Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma. Cancer Res (2009) 1.03
Gain of chromosome band 7q11 in papillary thyroid carcinomas of young patients is associated with exposure to low-dose irradiation. Proc Natl Acad Sci U S A (2011) 1.02
Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging. J Proteome Res (2012) 1.02
Characterization of eight different tetracyclines: advances in fluorescence bone labeling. J Anat (2010) 0.97
Evaluation of different biomarkers to predict individual radiosensitivity in an inter-laboratory comparison--lessons for future studies. PLoS One (2012) 0.96
Chromosomal imbalances are associated with metastasis-free survival in breast cancer patients. Anal Cell Pathol (2002) 0.96
Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment. J Clin Invest (2015) 0.95
Array-based comparative genomic hybridization for the detection of DNA sequence copy number changes in Barrett's adenocarcinoma. J Pathol (2004) 0.93
Clinical response to chemotherapy in oesophageal adenocarcinoma patients is linked to defects in mitochondria. J Pathol (2013) 0.92
Effects of simultaneous knockdown of HER2 and PTK6 on malignancy and tumor progression in human breast cancer cells. Mol Cancer Res (2013) 0.92
Chromosomal changes characterize head and neck cancer with poor prognosis. J Mol Med (Berl) (2008) 0.92
MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma. J Proteomics (2012) 0.92
Time-course of radiation-induced chromosomal aberrations in tumor patients after radiotherapy. Int J Radiat Oncol Biol Phys (2005) 0.90
Chromosomal radiosensitivity and acute radiation side effects after radiotherapy in tumour patients--a follow-up study. Radiat Oncol (2011) 0.90
Matching of array CGH and gene expression microarray features for the purpose of integrative genomic analyses. BMC Bioinformatics (2012) 0.90
S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging. J Mol Med (Berl) (2011) 0.89
Mycoplasma contamination of murine embryonic stem cells affects cell parameters, germline transmission and chimeric progeny. Transgenic Res (2008) 0.89
Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations. Endocr Relat Cancer (2010) 0.88
Distinct chromosomal imbalances in nonpolypoid and polypoid colorectal adenomas indicate different genetic pathways in the development of colorectal neoplasms. Am J Pathol (2003) 0.88
Coamplification and coexpression of GRB7 and ERBB2 is found in high grade intraepithelial neoplasia and in invasive Barrett's carcinoma. Int J Cancer (2004) 0.88
Overexpression of PTK6 (breast tumor kinase) protein--a prognostic factor for long-term breast cancer survival--is not due to gene amplification. Virchows Arch (2009) 0.87
Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma. HPB (Oxford) (2011) 0.86
Radiation-induced late effects in two affected individuals of the Lilo radiation accident. Radiat Res (2007) 0.85
Molecular rearrangements in papillary thyroid carcinomas. Clin Chim Acta (2009) 0.84
Distribution and quantification of irinotecan and its active metabolite SN-38 in colon cancer murine model systems using MALDI MSI. Anal Bioanal Chem (2014) 0.84
Chromosomal imbalances in post-chernobyl thyroid tumors. Thyroid (2004) 0.83
Dose-dependent expression of CLIP2 in post-Chernobyl papillary thyroid carcinomas. Carcinogenesis (2015) 0.82
Proteomic analysis by SILAC and 2D-DIGE reveals radiation-induced endothelial response: four key pathways. J Proteomics (2012) 0.82
Multicentric investigation of ionising radiation-induced cell death as a predictive parameter of individual radiosensitivity. Apoptosis (2009) 0.82
Establishment of an x-ray standard calibration curve by conventional dicentric analysis as prerequisite for accurate radiation dose assessment. Health Phys (2010) 0.80
Association of radiation-induced genes with noncancer chronic diseases in Mayak workers occupationally exposed to prolonged radiation. Radiat Res (2015) 0.79
Chromosomal rearrangements in post-Chernobyl papillary thyroid carcinomas: evaluation by spectral karyotyping and automated interphase FISH. J Biomed Biotechnol (2011) 0.79
Novel approach of MALDI drug imaging, immunohistochemistry, and digital image analysis for drug distribution studies in tissues. Anal Chem (2014) 0.79
Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells. Mol Cancer (2014) 0.78
Xrs2 facilitates crossovers during DNA double-strand gap repair in yeast. DNA Repair (Amst) (2008) 0.78
Gene amplification of atypical PKC-binding PARD3 in radiation-transformed neoplastic retinal pigment epithelial cell lines. Genes Chromosomes Cancer (2004) 0.78
Novel candidate genes of thyroid tumourigenesis identified in Trk-T1 transgenic mice. Endocr Relat Cancer (2012) 0.77
Genetic and biochemical analysis of base excision repair complexes participating in radiation-induced ROS damage repair. Radiat Prot Dosimetry (2010) 0.76
RET/PTC rearrangement occurring in primary peritoneal carcinoma. Int J Surg Pathol (2009) 0.76
Independent validation of candidate genes identified after a whole genome screening on Mayak workers exposed to prolonged occupational radiation. Radiat Res (2014) 0.76
Chromosomal aberrations in thyroid follicular-cell neoplasia: in the search of novel oncogenes and tumour suppressor genes. Mol Cell Endocrinol (2009) 0.76
The impact of cysteine-rich intestinal protein 1 (CRIP1) in human breast cancer. Mol Cancer (2013) 0.76
MLL gene alterations in radiation-associated acute myeloid leukemia. Exp Oncol (2005) 0.76
Aml1 gene rearrangements and mutations in radiation-associated acute myeloid leukemia and myelodysplastic syndromes. J Radiat Res (2005) 0.75
Molecular cytogenetic analysis of chemoresistant non-Hodgkin's lymphoma patients with p53 abnormalities using fluorescence in situ hybridisation and comparative genomic hybridisation. Arch Iran Med (2011) 0.75
Gene expression analysis in Mayak workers with prolonged occupational radiation exposure. Health Phys (2014) 0.75
Novel human prostate cell lines derived from the transition and peripheral zones of the prostate for carcinogenesis studies. Oncol Rep (2011) 0.75